UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
This intro breaks down zero based budgeting for families into easy steps, helping you implement a solid plan without overwhelm.
17,962 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A sharp intraday drop in Micron shares sparked by AI memory demand concerns set off a broader discussion about pricin...
As March moves unfold, the stock market today is colored by big auto headlines. Ford’s recall news sent ripples throu...
As July 29 approaches, investors eye Microsoft’s Q4 results for a potential breakout. This article lays out why the s...
Tesla’s foray into robotics and AI promises upside, but it also introduces new risks for shareholders. This guide bre...
Public disclosures show surprising activity in major names, but smart investing hinges on fundamentals, risk, and a d...
In March, fintech headlines are driving volatility and opportunity. SoFi’s latest collaboration with Mastercard on st...
Meta's push into cloud services could reshape AI compute bets. Learn how Nebius and CoreWeave investors might respond...
As the CLARITY Act stalls in the Senate, the Trump administration escalates pressure on banks to unlock crypto bankin...
Large holders continue to add ADA as smaller investors trim positions, signaling a strategic shift even as sentiment ...
Strategy's STRC is shaping up as the backbone of a new yield-backed stablecoin ecosystem, with a boosted monthly divi...
Investors obsess over the idea of a spacex stock millionaire maker? But the truth hinges on two big factors. This gui...